\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ underwent\\ excision\\ of\\ the\\ lesion\\ and\\ evacuation\\ of\\ the\\ hematoma\\.\ \(0\)\
\-\ ct\\ followed\\ by\\ mr\\ \\(fig\\.\\ 1a\\-f\\)\\ demonstrated\\ a\\ nodular\\ lesion\\ in\\ the\\ right\\ frontal\\ subcortical\\ region\\,\\ surrounded\\ by\\ an\\ area\\ of\\ hematoma\\ in\\ late\\ subacute\\ stage\\ and\\ by\\ hyperintense\\ perilesional\\ oedema\\ on\\ t1wi\\.\ \(0\)\
\-\ cerebral\\ cavernous\\ malformation\\.\ \(0\)\
\-\ the\\ differential\\ diagnosis\\ was\\ between\\ cerebral\\ cavernous\\ malformation\\ \\(ccm\\,\\ cavernoma\\)\\ and\\ haemorrhagic\\ metastasis\\.\ \(0\)\
\-\ a\\ 33\\-year\\-old\\ man\\ presented\\ with\\ headache\\,\\ left\\ hemiparesis\\,\\ hemihypoesthesia\\ and\\ partial\\ seizures\\ of\\ the\\ left\\ arm\\ for\\ a\\ week\\.\\ no\\ personal\\ or\\ familial\\ significant\\ history\\ was\\ present\\.\ \(0\)\
\-\ companion\\ cases\\:\\ http\\:\\/\\/goo\\.gl\\/tx2xvc\ \(0\)\
\-\ ccm\\ is\\ considered\\ the\\ third\\ most\\ prevalent\\ vascular\\ malformation\\ of\\ the\\ brain\\,\\ after\\ development\\ venous\\ anomaly\\ \\(dva\\)\\ and\\ capillary\\ telangiectasia\\,\\ affecting\\ 0\\.5\\%\\ to\\ 0\\.7\\%\\ of\\ the\\ population\\.\\ \ \(0\)\
\-\ histologically\\,\\ ccm\\ is\\ formed\\ by\\ dilated\\ capillaries\\ without\\ elastic\\ and\\ muscular\\ tunics\\,\\ which\\ makes\\ it\\ susceptible\\ to\\ multiple\\ bleedings\\ and\\ explains\\ the\\ mr\\ appearance\\ of\\ haemorrhage\\ in\\ different\\ phases\\ of\\ evolution\\.\\ it\\ is\\ limited\\ at\\ the\\ periphery\\ by\\ a\\ pseudocapsule\\ of\\ gliotic\\ brain\\ infiltrated\\ by\\ hemosiderin\\,\\ resulting\\ in\\ a\\ hypointense\\ peripheral\\ ring\\ on\\ t2wi\\.\\ when\\ associated\\ with\\ dva\\,\\ the\\ main\\ hypothesis\\ of\\ the\\ pathogenesis\\ of\\ ccm\\ sustains\\ that\\ the\\ first\\ step\\ is\\ a\\ hyperpressure\\ in\\ a\\ branch\\ of\\ the\\ dva\\.\\ this\\ produces\\ high\\ pressure\\ in\\ the\\ capillary\\ bed\\ and\\ chronic\\ microbleeds\\ which\\ stimulate\\ fibroblastic\\ and\\ endothelial\\ proliferation\\ with\\ the\\ final\\ result\\ of\\ ccm\\.\\ as\\ well\\,\\ cavernoma\\ can\\ also\\ occur\\ as\\ a\\ result\\ of\\ radiation\\ injury\\,\\ through\\ a\\ similar\\ mechanism\\ of\\ proliferation\\ and\\ dilatation\\ of\\ the\\ vascular\\ endothelium\\ and\\ capillaries\\.\ \(0\)\
\-\ ccm\\ can\\ affect\\ all\\ cerebral\\ regions\\,\\ albeit\\ it\\ is\\ more\\ frequent\\ in\\ the\\ subcortical\\ areas\\ of\\ frontal\\ and\\ temporal\\ lobes\\.\\ when\\ situated\\ in\\ the\\ posterior\\ fossa\\,\\ it\\ has\\ a\\ tendency\\ to\\ involve\\ the\\ pons\\ and\\ the\\ cerebellar\\ hemispheres\\.\\ one\\ third\\ to\\ one\\ half\\ of\\ ccm\\ are\\ clinically\\ silent\\.\\ the\\ symptomatology\\ is\\ usually\\ associated\\ with\\ haemorrhagic\\ events\\.\ \(0\)\
\-\ there\\ are\\ different\\ forms\\ to\\ classify\\ ccm\\,\\ the\\ most\\ used\\ being\\ the\\ sporadic\\ versus\\ familial\\ forms\\ and\\ the\\ zabramski\\ classification\\.\\ the\\ sporadic\\ form\\ usually\\ presents\\ as\\ a\\ unique\\ lesion\\ and\\ it\\ has\\ strong\\ association\\ with\\ dva\\ which\\ is\\ commonly\\ adjacent\\ to\\ the\\ ccm\\ and\\ involved\\ in\\ its\\ pathogenesis\\.\\ on\\ the\\ other\\ hand\\,\\ the\\ familial\\ form\\ is\\ represented\\ by\\ multiple\\ lesions\\,\\ has\\ no\\ association\\ with\\ dva\\ and\\ it\\ does\\ have\\ higher\\ risk\\ of\\ complications\\.\\ the\\ zabramski\\ classification\\ is\\ based\\ on\\ the\\ haemorrhagic\\ aspect\\ of\\ ccm\\ and\\ includes\\:\\ type\\ 1\\,\\ subacute\\ haemorrhage\\ \\(hyperintense\\ on\\ t1wi\\,\\ hyper\\-\\ or\\ hypointense\\ on\\ t2wi\\)\\,\\ type\\ 2\\,\\ \\"popcorn\\ ball\\"\\ appearance\\ \\(mixed\\-signal\\ intensity\\ on\\ t1\\-\\ and\\ t2wi\\,\\ hypointense\\ ring\\ on\\ t2wi\\)\\,\\ type\\ 3\\,\\ chronic\\ haemorrhage\\ \\(iso\\-\\ or\\ hypointense\\ on\\ t1\\-\\ and\\ t2wi\\,\\ also\\ hypointense\\ ring\\)\\ and\\ type\\ 4\\,\\ patchy\\ microbleeds\\ \\(punctate\\ hyperintense\\ lesions\\ on\\ t2\\*\\,\\ \\"black\\ dots\\"\\)\\.\ \(0\)\
\-\ on\\ ct\\,\\ up\\ to\\ half\\ of\\ ccm\\ cannot\\ be\\ identified\\,\\ the\\ others\\ being\\ slightly\\ hyperdense\\,\\ well\\ defined\\,\\ sometimes\\ with\\ calcifications\\.\\ the\\ mr\\ appearance\\ is\\ heterogeneous\\,\\ consequence\\ of\\ different\\ stages\\ of\\ haemorrhage\\.\\ a\\ hypointense\\ peripheral\\ ring\\ frequently\\ appears\\ on\\ t2wi\\,\\ explained\\ by\\ the\\ presence\\ of\\ hemosiderin\\.\\ on\\ t2\\*\\-gradient\\ recalled\\ echo\\ \\(gre\\)\\ and\\ susceptibility\\-weighted\\ imaging\\ \\(swi\\)\\ it\\ manifests\\ high\\ susceptibility\\ magnetic\\ properties\\,\\ presenting\\ pronounced\\ hypointense\\ signal\\.\\ when\\ a\\ ccm\\ is\\ studied\\,\\ the\\ administration\\ of\\ contrast\\ is\\ recommended\\ in\\ order\\ to\\ search\\ for\\ a\\ dva\\.\\ the\\ reasons\\ are\\ the\\ high\\ association\\ between\\ the\\ two\\ malformations\\ and\\,\\ more\\ importantly\\,\\ when\\ dealing\\ with\\ a\\ surgical\\ ccm\\,\\ being\\ aware\\ of\\ the\\ presence\\ of\\ a\\ dva\\ is\\ essential\\ in\\ order\\ to\\ avoid\\ a\\ venous\\ infarct\\ which\\ would\\ result\\ from\\ cutting\\ the\\ dva\\.\\ ccm\\ usually\\ does\\ not\\ enhance\\.\\ sometimes\\ it\\ is\\ difficult\\ to\\ differentiate\\ a\\ complicated\\ cavernoma\\ from\\ a\\ haemorrhagic\\ neoplasm\\.\\ noteworthily\\,\\ it\\ was\\ showed\\ that\\ hyperintense\\ perilesional\\ signal\\ on\\ t1wi\\ can\\ be\\ seen\\ in\\ more\\ than\\ half\\ of\\ the\\ patients\\ with\\ ccm\\,\\ this\\ being\\ of\\ particular\\ value\\ when\\ the\\ diagnosis\\ is\\ uncertain\\ and\\ a\\ therapeutic\\ decision\\ is\\ required\\ \\[ajnr\\ 2008\\;29\\:494\\â\\€\\“500\\]\\.\ \(0\)\
\-\ references\ \(24\)\
\-\ yun\\ tj\\,\\ na\\ dg\\,\\ kwon\\ bj\\,\\ rho\\ hg\\,\\ park\\ s\\-h\\,\\ suh\\ y\\-l\\,\\ et\\ al\\.\\ a\\ t1\\ hyperintense\\ perilesional\\ signal\\ aids\\ in\\ the\\ differentiation\\ of\\ a\\ cavernous\\ angioma\\ from\\ other\\ hemorrhagic\\ masses\\.\\ ajnr\\ am\\ j\\ neuroradiol\\ 2008\\;29\\:494\\â\\€\\“500\\.\ \(0\)\
\-\ petersen\\ t\\ a\\,\\ morrison\\ l\\ a\\,\\ schrader\\ rm\\,\\ hart\\ bl\\.\\ familial\\ versus\\ sporadic\\ cavernous\\ malformations\\:\\ differences\\ in\\ developmental\\ venous\\ anomaly\\ association\\ and\\ lesion\\ phenotype\\.\\ ajnr\\ am\\ j\\ neuroradiol\\ 2010\\;31\\:377\\â\\€\\“82\\.\ \(0\)\
\-\ zabramski\\ jm\\,\\ wascher\\ tm\\,\\ spetzler\\ rf\\,\\ johnson\\ b\\,\\ golfinos\\ j\\,\\ drayer\\ bp\\,\\ et\\ al\\.\\ the\\ natural\\ history\\ of\\ familial\\ cavernous\\ malformations\\:\\ results\\ of\\ an\\ ongoing\\ study\\.\\ j\\ neurosurg\\ 1994\\;80\\:422\\â\\€\\“32\\.\ \(0\)\
\-\ cort\\Ã\\©s\\ vela\\ jj\\,\\ concepci\\Ã\\³n\\ aramend\\Ã\\­a\\ l\\,\\ ballenilla\\ marco\\ f\\,\\ gallego\\ le\\Ã\\³n\\ ji\\,\\ gonz\\Ã\\¡lez\\-sp\\Ã\\­nola\\ san\\ gil\\ j\\.\\ cerebral\\ cavernous\\ malformations\\:\\ spectrum\\ of\\ neuroradiological\\ findings\\.\\ radiologia\\ 2012\\;54\\:401\\â\\€\\“9\\.\ \(0\)\
\-\ al\\-shahi\\ salman\\ r\\,\\ hall\\ jm\\,\\ horne\\ ma\\,\\ moultrie\\ f\\,\\ josephson\\ cb\\,\\ bhattacharya\\ jj\\,\\ et\\ al\\.\\ untreated\\ clinical\\ course\\ of\\ cerebral\\ cavernous\\ malformations\\:\\ a\\ prospective\\,\\ population\\-based\\ cohort\\ study\\.\\ lancet\\ neurol\\ 2012\\;11\\:217\\â\\€\\“24\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ccm\\:\\ 0\\.13030542101721743\ \(0\)\
\-\ dva\\:\\ 0\\.05284672594097317\ \(0\)\
\-\ haemorrhagic\\:\\ 0\\.037713447803065236\ \(0\)\
\-\ t2wi\\:\\ 0\\.03289821798835869\ \(0\)\
\-\ haemorrhage\\:\\ 0\\.030828151920994216\ \(0\)\
\-\ hypointense\\:\\ 0\\.030345894571316784\ \(0\)\
\-\ cavernous\\:\\ 0\\.02967317339072531\ \(0\)\
\-\ familial\\:\\ 0\\.0279786068743871\ \(0\)\
\-\ malformations\\:\\ 0\\.02552121473867352\ \(0\)\
\-\ cavernoma\\:\\ 0\\.022536124988465592\ \(0\)\
\-\ ajnr\\:\\ 0\\.021613080905732607\ \(0\)\
\-\ perilesional\\:\\ 0\\.020591304228346933\ \(0\)\
\-\ \\,\\:\\ 0\\.019108945801220287\ \(0\)\
\-\ hyperintense\\:\\ 0\\.01897144526686187\ \(0\)\
\-\ zabramski\\:\\ 0\\.018856723901532618\ \(0\)\
\-\ 29\\:494\\â\\€\\“500\\:\\ 0\\.018856723901532618\ \(0\)\
\-\ it\\:\\ 0\\.01848944969069214\ \(0\)\
\-\ association\\:\\ 0\\.017762906223976176\ \(0\)\
\-\ sporadic\\:\\ 0\\.017710208207365248\ \(0\)\
\-\ ring\\:\\ 0\\.01698965278078249\ \(0\)\
\-\ t1wi\\:\\ 0\\.016877551965167117\ \(0\)\
\-\ j\\:\\ 0\\.016512048626161444\ \(0\)\
\-\ microbleeds\\:\\ 0\\.016506751091547357\ \(0\)\
\-\ t1\\-\\:\\ 0\\.016506751091547357\ \(0\)\
\-\ cerebral\\:\\ 0\\.015831264715315888\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.01469434925114692\ \(0\)\
\-\ jj\\:\\ 0\\.01469434925114692\ \(0\)\
\-\ half\\:\\ 0\\.014475251328649182\ \(0\)\
\-\ capillaries\\:\\ 0\\.013931408194593481\ \(0\)\
\-\ different\\:\\ 0\\.013573960252286394\ \(0\)\
\-\ jm\\:\\ 0\\.013370201211775318\ \(0\)\
\-\ when\\:\\ 0\\.013087332821475966\ \(0\)\
\-\ \\;\\:\\ 0\\.012997355220016644\ \(0\)\
\-\ being\\:\\ 0\\.012739199900751052\ \(0\)\
\-\ pathogenesis\\:\\ 0\\.01255845870545467\ \(0\)\
\-\ type\\:\\ 0\\.012323526110575017\ \(0\)\
\-\ by\\:\\ 0\\.01217429649835187\ \(0\)\
\-\ hemosiderin\\:\\ 0\\.011653952072684543\ \(0\)\
\-\ 2012\\:\\ 0\\.011653952072684543\ \(0\)\
\-\ al\\:\\ 0\\.011623192213078998\ \(0\)\
\-\ et\\:\\ 0\\.01122159924103406\ \(0\)\
\-\ subcortical\\:\\ 0\\.011132835318336413\ \(0\)\
\-\ proliferation\\:\\ 0\\.011020228401790058\ \(0\)\
\-\ malformation\\:\\ 0\\.010935871612319934\ \(0\)\
\-\ on\\:\\ 0\\.010839009810819243\ \(0\)\
\-\ capillary\\:\\ 0\\.010762200620424036\ \(0\)\
\-\ forms\\:\\ 0\\.010621114058302546\ \(0\)\
\-\ a\\:\\ 0\\.01060427277589843\ \(0\)\
\-\ 2008\\:\\ 0\\.01057608002793285\ \(0\)\
\-\ result\\:\\ 0\\.010518237936731428\ \(0\)\
\-\ classification\\:\\ 0\\.010446401692496625\ \(0\)\
\-\ \\*\\:\\ 0\\.010171284306780918\ \(0\)\
\-\ venous\\:\\ 0\\.00995225332125282\ \(0\)\
\-\ is\\:\\ 0\\.009622088186262685\ \(0\)\
\-\ f\\:\\ 0\\.00953756063588643\ \(0\)\
\-\ 1a\\-f\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ hemihypoesthesia\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ \\/\\/goo\\.gl\\/tx2xvc\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ tunics\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ bleedings\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ sustains\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ hyperpressure\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ mixed\\-signal\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ \\-gradient\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ susceptibility\\-weighted\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ noteworthily\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ \\-yun\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ rho\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ s\\-h\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ suh\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ y\\-l\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ \\-petersen\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ schrader\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ 31\\:377\\â\\€\\“82\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ \\-zabramski\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ wascher\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ golfinos\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ 80\\:422\\â\\€\\“32\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ \\-cort\\Ã\\©s\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ vela\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ concepci\\Ã\\³n\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ aramend\\Ã\\­a\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ ballenilla\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ marco\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ gallego\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ le\\Ã\\³n\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ gonz\\Ã\\¡lez\\-sp\\Ã\\­nola\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ neuroradiological\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ radiologia\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ 54\\:401\\â\\€\\“9\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ \\-al\\-shahi\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ salman\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ horne\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ moultrie\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ josephson\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ bhattacharya\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ 11\\:217\\â\\€\\“24\\:\\ 0\\.009428361950766309\ \(0\)\
\-\ am\\:\\ 0\\.009404658430309947\ \(0\)\
\-\ subacute\\:\\ 0\\.009379040909354404\ \(0\)\
\-\ sometimes\\:\\ 0\\.009303979262699283\ \(0\)\
\-\ order\\:\\ 0\\.009161323916178058\ \(0\)\
\-\ anomaly\\:\\ 0\\.009049306834857596\ \(0\)\
\-\ mr\\:\\ 0\\.008711869963464495\ \(0\)\
\-\ versus\\:\\ 0\\.008688616540877292\ \(0\)\
\-\ oedema\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ gliotic\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ swi\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ kwon\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ hart\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ spetzler\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ drayer\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ gil\\:\\ 0\\.008687028067814495\ \(0\)\
\-\ form\\:\\ 0\\.008545961194356067\ \(0\)\
\-\ \\:\\:\\ 0\\.008461950494047759\ \(0\)\
\-\ l\\:\\ 0\\.00833270053077727\ \(0\)\
\-\ usually\\:\\ 0\\.008325973007059121\ \(0\)\
\-\ can\\:\\ 0\\.00829186033141848\ \(0\)\
\-\ hyper\\-\\:\\ 0\\.008253375545773678\ \(0\)\
\-\ dots\\:\\ 0\\.008253375545773678\ \(0\)\
\-\ dealing\\:\\ 0\\.008253375545773678\ \(0\)\
\-\ ji\\:\\ 0\\.008253375545773678\ \(0\)\
\-\ cb\\:\\ 0\\.008253375545773678\ \(0\)\
\-\ endothelium\\:\\ 0\\.007945694184862682\ \(0\)\
\-\ classify\\:\\ 0\\.007945694184862682\ \(0\)\
\-\ johnson\\:\\ 0\\.007945694184862682\ \(0\)\
\-\ appearance\\:\\ 0\\.00784141147615393\ \(0\)\
\-\ 33\\-year\\-old\\:\\ 0\\.007707037980248554\ \(0\)\
\-\ pseudocapsule\\:\\ 0\\.007707037980248554\ \(0\)\
\-\ fibroblastic\\:\\ 0\\.007707037980248554\ \(0\)\
\-\ cutting\\:\\ 0\\.007707037980248554\ \(0\)\
\-\ tj\\:\\ 0\\.007707037980248554\ \(0\)\
\-\ phenotype\\:\\ 0\\.007707037980248554\ \(0\)\
\-\ cohort\\:\\ 0\\.007707037980248554\ \(0\)\
\-\ explains\\:\\ 0\\.007512041662821864\ \(0\)\
\-\ hall\\:\\ 0\\.007512041662821864\ \(0\)\
\-\ population\\-based\\:\\ 0\\.007512041662821864\ \(0\)\
\-\ lancet\\:\\ 0\\.007512041662821864\ \(0\)\
\-\ high\\:\\ 0\\.007503356345701013\ \(0\)\
\-\ lesion\\:\\ 0\\.007446225565777346\ \(0\)\
\-\ albeit\\:\\ 0\\.00734717462557346\ \(0\)\
\-\ studied\\:\\ 0\\.00734717462557346\ \(0\)\
\-\ park\\:\\ 0\\.00734717462557346\ \(0\)\
\-\ third\\:\\ 0\\.00732929774149732\ \(0\)\
\-\ signal\\:\\ 0\\.007229115498201429\ \(0\)\
\-\ situated\\:\\ 0\\.007204360301910869\ \(0\)\
\-\ recalled\\:\\ 0\\.007204360301910869\ \(0\)\
\-\ properties\\:\\ 0\\.007204360301910869\ \(0\)\
\-\ neurol\\:\\ 0\\.007204360301910869\ \(0\)\
\-\ elastic\\:\\ 0\\.007078389140781047\ \(0\)\
\-\ stimulate\\:\\ 0\\.007078389140781047\ \(0\)\
\-\ represented\\:\\ 0\\.007078389140781047\ \(0\)\
\-\ susceptibility\\:\\ 0\\.007078389140781047\ \(0\)\
\-\ morrison\\:\\ 0\\.007078389140781047\ \(0\)\
\-\ rm\\:\\ 0\\.007078389140781047\ \(0\)\
\-\ bl\\:\\ 0\\.007078389140781047\ \(0\)\
\-\ infiltrated\\:\\ 0\\.006965704097296741\ \(0\)\
\-\ hypothesis\\:\\ 0\\.006965704097296741\ \(0\)\
\-\ tendency\\:\\ 0\\.006965704097296741\ \(0\)\
\-\ importantly\\:\\ 0\\.006965704097296741\ \(0\)\
\-\ dg\\:\\ 0\\.006965704097296741\ \(0\)\
\-\ differences\\:\\ 0\\.006965704097296741\ \(0\)\
\-\ \\(\\:\\ 0\\.0069532144772136316\ \(0\)\
\-\ \\)\\:\\ 0\\.006868277250288499\ \(0\)\
\-\ prevalent\\:\\ 0\\.006863768076115644\ \(0\)\
\-\ step\\:\\ 0\\.006863768076115644\ \(0\)\
\-\ silent\\:\\ 0\\.006863768076115644\ \(0\)\
\-\ iso\\-\\:\\ 0\\.006863768076115644\ \(0\)\
\-\ consequence\\:\\ 0\\.006863768076115644\ \(0\)\
\-\ more\\:\\ 0\\.006857250190306416\ \(0\)\
\-\ which\\:\\ 0\\.006824147966813043\ \(0\)\
\-\ personal\\:\\ 0\\.006770707779870051\ \(0\)\
\-\ endothelial\\:\\ 0\\.006770707779870051\ \(0\)\
\-\ susceptible\\:\\ 0\\.006685100605887659\ \(0\)\
\-\ bj\\:\\ 0\\.006685100605887659\ \(0\)\
\-\ neurosurg\\:\\ 0\\.006685100605887659\ \(0\)\
\-\ san\\:\\ 0\\.006685100605887659\ \(0\)\
\-\ the\\:\\ 0\\.006653708889479316\ \(0\)\
\-\ presence\\:\\ 0\\.00663483554750188\ \(0\)\
\-\ peripheral\\:\\ 0\\.0066137611166077375\ \(0\)\
\-\ manifests\\:\\ 0\\.0066058407426216464\ \(0\)\
\-\ aware\\:\\ 0\\.006532051575255923\ \(0\)\
\-\ hematoma\\:\\ 0\\.006504741985929604\ \(0\)\
\-\ histologically\\:\\ 0\\.006463026418959055\ \(0\)\
\-\ popcorn\\:\\ 0\\.0063981872512409435\ \(0\)\
\-\ rf\\:\\ 0\\.0063981872512409435\ \(0\)\
\-\ gre\\:\\ 0\\.006337055257829234\ \(0\)\
\-\ hg\\:\\ 0\\.006337055257829234\ \(0\)\
\-\ in\\:\\ 0\\.0063096911464851\ \(0\)\
\-\ ma\\:\\ 0\\.006279229352727335\ \(0\)\
\-\ does\\:\\ 0\\.006236622610447073\ \(0\)\
\-\ telangiectasia\\:\\ 0\\.006172188220580829\ \(0\)\
\-\ 0\\.7\\:\\ 0\\.006172188220580829\ \(0\)\
\-\ evolution\\:\\ 0\\.006172188220580829\ \(0\)\
\-\ events\\:\\ 0\\.006172188220580829\ \(0\)\
\-\ explained\\:\\ 0\\.006172188220580829\ \(0\)\
\-\ 1994\\:\\ 0\\.006172188220580829\ \(0\)\
\-\ tm\\:\\ 0\\.006122434193163832\ \(0\)\
\-\ natural\\:\\ 0\\.006074892201109464\ \(0\)\
\-\ untreated\\:\\ 0\\.006029373896918238\ \(0\)\
\-\ prospective\\:\\ 0\\.006029373896918238\ \(0\)\
\-\ study\\:\\ 0\\.006014184720556062\ \(0\)\
\-\ vascular\\:\\ 0\\.00599316207042502\ \(0\)\
\-\ phases\\:\\ 0\\.005985714009730799\ \(0\)\
\-\ search\\:\\ 0\\.005943766722935846\ \(0\)\
\-\ decision\\:\\ 0\\.005943766722935846\ \(0\)\
\-\ symptomatology\\:\\ 0\\.005903402735788417\ \(0\)\
\-\ evacuation\\:\\ 0\\.005864506859669833\ \(0\)\
\-\ unique\\:\\ 0\\.005826976036342271\ \(0\)\
\-\ between\\:\\ 0\\.005793573339517099\ \(0\)\
\-\ pronounced\\:\\ 0\\.00579071769230411\ \(0\)\
\-\ essential\\:\\ 0\\.00579071769230411\ \(0\)\
\-\ uncertain\\:\\ 0\\.00575564836308166\ \(0\)\
\-\ ongoing\\:\\ 0\\.00575564836308166\ \(0\)\
\-\ frontal\\:\\ 0\\.0057418009293761655\ \(0\)\
\-\ aids\\:\\ 0\\.0057216925360072425\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.0056887816711230135\ \(0\)\
\-\ fig\\:\\ 0\\.00565685336828913\ \(0\)\
\-\ 0\\.5\\:\\ 0\\.00565685336828913\ \(0\)\
\-\ formed\\:\\ 0\\.00565685336828913\ \(0\)\
\-\ produces\\:\\ 0\\.00565685336828913\ \(0\)\
\-\ 2010\\:\\ 0\\.00565685336828913\ \(0\)\
\-\ companion\\:\\ 0\\.005537895469775522\ \(0\)\
\-\ ball\\:\\ 0\\.005510114200895029\ \(0\)\
\-\ brain\\:\\ 0\\.005500217162144946\ \(0\)\
\-\ stages\\:\\ 0\\.0054830363313931145\ \(0\)\
\-\ muscular\\:\\ 0\\.005430854337629016\ \(0\)\
\-\ reasons\\:\\ 0\\.005430854337629016\ \(0\)\
\-\ others\\:\\ 0\\.005381100310212018\ \(0\)\
\-\ differentiate\\:\\ 0\\.005381100310212018\ \(0\)\
\-\ j\\.\\:\\ 0\\.005381100310212018\ \(0\)\
\-\ angioma\\:\\ 0\\.0053570651702632924\ \(0\)\
\-\ punctate\\:\\ 0\\.005333558318157651\ \(0\)\
\-\ bed\\:\\ 0\\.005310557029151273\ \(0\)\
\-\ strong\\:\\ 0\\.005310557029151273\ \(0\)\
\-\ avoid\\:\\ 0\\.005288040013966425\ \(0\)\
\-\ spectrum\\:\\ 0\\.005288040013966425\ \(0\)\
\-\ affect\\:\\ 0\\.005265987300380612\ \(0\)\
\-\ black\\:\\ 0\\.005265987300380612\ \(0\)\
\-\ magnetic\\:\\ 0\\.0052443801267789865\ \(0\)\
\-\ surrounded\\:\\ 0\\.005223200846248313\ \(0\)\
\-\ pons\\:\\ 0\\.005223200846248313\ \(0\)\
\-\ value\\:\\ 0\\.005182060438945858\ \(0\)\
\-\ t2\\:\\ 0\\.005173451911765459\ \(0\)\
\-\ has\\:\\ 0\\.00514876995880517\ \(0\)\
\-\ chronic\\:\\ 0\\.005148640926004278\ \(0\)\
\-\ therapeutic\\:\\ 0\\.00514244410559789\ \(0\)\
\-\ periphery\\:\\ 0\\.005104242947734704\ \(0\)\
\-\ affecting\\:\\ 0\\.005085642153390459\ \(0\)\
\-\ makes\\:\\ 0\\.0050673593369633995\ \(0\)\
\-\ one\\:\\ 0\\.0049534361140334635\ \(0\)\
\-\ branch\\:\\ 0\\.0049474477881712\ \(0\)\
\-\ final\\:\\ 0\\.004931364496872227\ \(0\)\
\-\ na\\:\\ 0\\.004931364496872227\ \(0\)\
\-\ patchy\\:\\ 0\\.004899905796116833\ \(0\)\
\-\ particular\\:\\ 0\\.004899905796116833\ \(0\)\
\-\ lesions\\:\\ 0\\.004893177553676894\ \(0\)\
\-\ hemispheres\\:\\ 0\\.004869346039492174\ \(0\)\
\-\ differentiation\\:\\ 0\\.004869346039492174\ \(0\)\
\-\ and\\:\\ 0\\.004813075019578034\ \(0\)\
\-\ \\]\\:\\ 0\\.004782580750922796\ \(0\)\
\-\ population\\:\\ 0\\.004768780317943215\ \(0\)\
\-\ \\[\\:\\ 0\\.004768780317943215\ \(0\)\
\-\ late\\:\\ 0\\.004755155691443291\ \(0\)\
\-\ echo\\:\\ 0\\.004755155691443291\ \(0\)\
\-\ complicated\\:\\ 0\\.004741702448441301\ \(0\)\
\-\ mechanism\\:\\ 0\\.004702329215154974\ \(0\)\
\-\ frequent\\:\\ 0\\.0045692231461994595\ \(0\)\
\-\ hyperdense\\:\\ 0\\.0045692231461994595\ \(0\)\
\-\ to\\:\\ 0\\.004567573352331404\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0044922674601750095\ \(0\)\
\-\ higher\\:\\ 0\\.004481866963296499\ \(0\)\
\-\ enhance\\:\\ 0\\.00442073496988479\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.004405881287662552\ \(0\)\
\-\ associated\\:\\ 0\\.004313288902476368\ \(0\)\
\-\ involve\\:\\ 0\\.004308049926400484\ \(0\)\
\-\ b\\:\\ 0\\.004308049926400484\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.004264390039213045\ \(0\)\
\-\ \\%\\:\\ 0\\.004263788306622477\ \(0\)\
\-\ main\\:\\ 0\\.004255867932636386\ \(0\)\
\-\ developmental\\:\\ 0\\.004247413195195623\ \(0\)\
\-\ of\\:\\ 0\\.004236501847199579\ \(0\)\
\-\ t\\:\\ 0\\.004230701625245803\ \(0\)\
\-\ most\\:\\ 0\\.004219968217600163\ \(0\)\
\-\ other\\:\\ 0\\.004213130585459783\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004197260600599829\ \(0\)\
\-\ regions\\:\\ 0\\.004182078765270662\ \(0\)\
\-\ r\\:\\ 0\\.004150849722819044\ \(0\)\
\-\ as\\:\\ 0\\.004147307505542656\ \(0\)\
\-\ well\\:\\ 0\\.0041349325197190395\ \(0\)\
\-\ from\\:\\ 0\\.004063430095681965\ \(0\)\
\-\ infarct\\:\\ 0\\.0040552277038718955\ \(0\)\
\-\ lobes\\:\\ 0\\.004027446434991403\ \(0\)\
\-\ resulting\\:\\ 0\\.004013821808491478\ \(0\)\
\-\ clinically\\:\\ 0\\.004007074033953227\ \(0\)\
\-\ difficult\\:\\ 0\\.004000368565489488\ \(0\)\
\-\ development\\:\\ 0\\.003980500773432873\ \(0\)\
\-\ bp\\:\\ 0\\.003967457700605259\ \(0\)\
\-\ frequently\\:\\ 0\\.003960995332203161\ \(0\)\
\-\ cerebellar\\:\\ 0\\.00394183926100901\ \(0\)\
\-\ seizures\\:\\ 0\\.0039292565427420725\ \(0\)\
\-\ dilatation\\:\\ 0\\.003916820138469218\ \(0\)\
\-\ stage\\:\\ 0\\.003898432544308392\ \(0\)\
\-\ limited\\:\\ 0\\.003856719006550885\ \(0\)\
\-\ defined\\:\\ 0\\.0038508905522540242\ \(0\)\
\-\ multiple\\:\\ 0\\.003849852413859399\ \(0\)\
\-\ nodular\\:\\ 0\\.00383359337659028\ \(0\)\
\-\ involved\\:\\ 0\\.00383359337659028\ \(0\)\
\-\ arm\\:\\ 0\\.003827889263247646\ \(0\)\
\-\ references\\:\\ 0\\.003799816294183543\ \(0\)\
\-\ administration\\:\\ 0\\.0037942890533723744\ \(0\)\
\-\ recommended\\:\\ 0\\.0037887902303772743\ \(0\)\
\-\ hand\\:\\ 0\\.0037563780918795963\ \(0\)\
\-\ excision\\:\\ 0\\.0037510702957917574\ \(0\)\
\-\ are\\:\\ 0\\.003737563227367706\ \(0\)\
\-\ fossa\\:\\ 0\\.003724919391124202\ \(0\)\
\-\ presenting\\:\\ 0\\.003724919391124202\ \(0\)\
\-\ slightly\\:\\ 0\\.003694359634499543\ \(0\)\
\-\ considered\\:\\ 0\\.003689350169994275\ \(0\)\
\-\ results\\:\\ 0\\.003689350169994275\ \(0\)\
\-\ includes\\:\\ 0\\.0036843640597206797\ \(0\)\
\-\ temporal\\:\\ 0\\.003659776339694264\ \(0\)\
\-\ partial\\:\\ 0\\.0036549259063622945\ \(0\)\
\-\ complications\\:\\ 0\\.0036215751818310772\ \(0\)\
\-\ also\\:\\ 0\\.0036034643714869547\ \(0\)\
\-\ pressure\\:\\ 0\\.003589233058633518\ \(0\)\
\-\ similar\\:\\ 0\\.0035846915710597738\ \(0\)\
\-\ used\\:\\ 0\\.0035060793122438094\ \(0\)\
\-\ based\\:\\ 0\\.003485230333975359\ \(0\)\
\-\ http\\:\\ 0\\.0034607364684281026\ \(0\)\
\-\ commonly\\:\\ 0\\.0034486967309686005\ \(0\)\
\-\ its\\:\\ 0\\.0034486967309686005\ \(0\)\
\-\ course\\:\\ 0\\.0034486967309686005\ \(0\)\
\-\ occur\\:\\ 0\\.00342892687570218\ \(0\)\
\-\ metastasis\\:\\ 0\\.0034211201350801356\ \(0\)\
\-\ appears\\:\\ 0\\.003401849006200266\ \(0\)\
\-\ calcifications\\:\\ 0\\.0033980361012115002\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.0033606365313315566\ \(0\)\
\-\ dilated\\:\\ 0\\.0033209533760338275\ \(0\)\
\-\ risk\\:\\ 0\\.003310381441025761\ \(0\)\
\-\ intensity\\:\\ 0\\.0033033910977318726\ \(0\)\
\-\ required\\:\\ 0\\.003289546001911512\ \(0\)\
\-\ identified\\:\\ 0\\.0032657401510014132\ \(0\)\
\-\ would\\:\\ 0\\.003252370992964802\ \(0\)\
\-\ or\\:\\ 0\\.003213441975284623\ \(0\)\
\-\ was\\:\\ 0\\.003170943921541241\ \(0\)\
\-\ that\\:\\ 0\\.0031571780290028306\ \(0\)\
\-\ headache\\:\\ 0\\.003139021858359142\ \(0\)\
\-\ underwent\\:\\ 0\\.003136038540618416\ \(0\)\
\-\ neoplasm\\:\\ 0\\.003112466926109014\ \(0\)\
\-\ week\\:\\ 0\\.0031037598056986395\ \(0\)\
\-\ masses\\:\\ 0\\.003089403634220414\ \(0\)\
\-\ areas\\:\\ 0\\.003075237616305954\ \(0\)\
\-\ first\\:\\ 0\\.003066827202979521\ \(0\)\
\-\ followed\\:\\ 0\\.0030640383651109855\ \(0\)\
\-\ cases\\:\\ 0\\.003044717501584099\ \(0\)\
\-\ radiation\\:\\ 0\\.002999199197392873\ \(0\)\
\-\ showed\\:\\ 0\\.00299658103521251\ \(0\)\
\-\ injury\\:\\ 0\\.0029135920234104815\ \(0\)\
\-\ differential\\:\\ 0\\.0029015613148159675\ \(0\)\
\-\ t1\\:\\ 0\\.0028967866697585496\ \(0\)\
\-\ area\\:\\ 0\\.0028896644322291627\ \(0\)\
\-\ adjacent\\:\\ 0\\.0028896644322291627\ \(0\)\
\-\ aspect\\:\\ 0\\.0028709004646880827\ \(0\)\
\-\ be\\:\\ 0\\.0028187309590244473\ \(0\)\
\-\ clinical\\:\\ 0\\.0028120960428513414\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0026817326015582538\ \(0\)\
\-\ not\\:\\ 0\\.002641323362014835\ \(0\)\
\-\ two\\:\\ 0\\.002617466564295193\ \(0\)\
\-\ through\\:\\ 0\\.002595675955530341\ \(0\)\
\-\ all\\:\\ 0\\.002584944908482664\ \(0\)\
\-\ region\\:\\ 0\\.0025813916868869654\ \(0\)\
\-\ ct\\:\\ 0\\.002556799258592605\ \(0\)\
\-\ 4\\:\\ 0\\.002546494016234273\ \(0\)\
\-\ an\\:\\ 0\\.0025276253781491547\ \(0\)\
\-\ history\\:\\ 0\\.0025245230753092695\ \(0\)\
\-\ presented\\:\\ 0\\.0024912915882592613\ \(0\)\
\-\ significant\\:\\ 0\\.00245759053588687\ \(0\)\
\-\ up\\:\\ 0\\.00245759053588687\ \(0\)\
\-\ than\\:\\ 0\\.002394704657666603\ \(0\)\
\-\ patients\\:\\ 0\\.0023653204271294396\ \(0\)\
\-\ 1\\:\\ 0\\.002174680607443537\ \(0\)\
\-\ man\\:\\ 0\\.0021614244311122985\ \(0\)\
\-\ without\\:\\ 0\\.0021518857394204924\ \(0\)\
\-\ imaging\\:\\ 0\\.0021412554272252434\ \(0\)\
\-\ 3\\:\\ 0\\.0021400807772262455\ \(0\)\
\-\ posterior\\:\\ 0\\.0021065652927298915\ \(0\)\
\-\ present\\:\\ 0\\.0020641804854884286\ \(0\)\
\-\ this\\:\\ 0\\.00205590847767729\ \(0\)\
\-\ contrast\\:\\ 0\\.002045749397655514\ \(0\)\
\-\ left\\:\\ 0\\.0020451449610115824\ \(0\)\
\-\ have\\:\\ 0\\.0019790781586792425\ \(0\)\
\-\ 2\\:\\ 0\\.00196802619947652\ \(0\)\
\-\ findings\\:\\ 0\\.0019452801452299034\ \(0\)\
\-\ surgical\\:\\ 0\\.0019210928024079718\ \(0\)\
\-\ after\\:\\ 0\\.0018909103771221417\ \(0\)\
\-\ presents\\:\\ 0\\.0018669992465325412\ \(0\)\
\-\ no\\:\\ 0\\.0018405222474947637\ \(0\)\
\-\ seen\\:\\ 0\\.0018060188396445886\ \(0\)\
\-\ \\.\\:\\ 0\\.0016705664045810011\ \(0\)\
\-\ for\\:\\ 0\\.0015595896227651662\ \(0\)\
\-\ there\\:\\ 0\\.001360123589802127\ \(0\)\
\-\ at\\:\\ 0\\.0012382493613172546\ \(0\)\
\-\ with\\:\\ 0\\.0011262434062128425\ \(0\)\
\-\ right\\:\\ 0\\.0009643119883533868\ \(0\)\
\-\ patient\\:\\ 0\\.0009161411025843722\ \(0\)\
